- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
PIL against 10 top pharma Cos in SC alleging sale of Remdesivir and Favipiravir without valid license
It has also made 10 pharmaceutical companies, including Cipla Ltd, Dr Reddy's Laboratories Ltd, Hetero Labs Ltd and Zydus Cadila Healthcare Ltd, parties.
New Delhi: A plea filed in the Supreme Court has sought registration of an FIR by CBI against ten Indian pharmaceutical firms for manufacturing and selling Remdesivir and Favipiravir allegedly as medicines that treat Covid-19 patients without valid licences. Remdesivir and Favipiravir are antiviral drugs and their efficacy in treating Covid-19 patients have been a matter of debate among...
New Delhi: A plea filed in the Supreme Court has sought registration of an FIR by CBI against ten Indian pharmaceutical firms for manufacturing and selling Remdesivir and Favipiravir allegedly as medicines that treat Covid-19 patients without valid licences. Remdesivir and Favipiravir are antiviral drugs and their efficacy in treating Covid-19 patients have been a matter of debate among medical experts.
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751